Share on PinterestThe FDA authorized the primary nonprescription sale of Dexcom’s steady glucose monitor for youngsters ages 2 to 18 with diabetes. Svetikd/Getty Photographs The Meals and Drug Administration (FDA) authorized the primary over-the-counter steady glucose monitor for youngsters below 18. Consultants say the over-the-counter model will make this useful know-how extra broadly obtainable to... Read More













:max_bytes(150000):strip_icc()/HDC-GettyImages-668641904-9179dc9fe60446d8b4d8a08fbffcf46d.jpg?w=600&resize=600,400&ssl=1)




Recent Comments